Feb 03, 2026
344:317
For every 317 shares held, investors received 344. The price per share adjusted from $10.75 to $9.91.
The split itself did not change the total investment value.
Neimeth International Pharmaceuticals PLC (NSENG:NEIMETH) operates in the Pharmaceuticals: major industry.
Neimeth International Pharmaceuticals PLC company overviewNeimeth International Pharmaceuticals PLC's most recent stock split was on February 3, 2026. It was a 344-for-317 forward split, so shareholders received 344 shares for every 317 they held.
Neimeth International Pharmaceuticals PLC (NSENG:NEIMETH) has split its stock 8 times: a 6-for-5 split on September 3, 2002, a 6-for-5 split on July 20, 2005, a 5-for-4 split on August 29, 2008, a 79-for-77 split on February 28, 2011, a 6-for-5 split on February 12, 2014, a 11-for-10 split on January 31, 2017, a 11-for-10 split on January 18, 2019, and a 344-for-317 split on February 3, 2026.
Neimeth International Pharmaceuticals PLC has split its stock 8 times. This history records 8 forward splits between September 3, 2002 and February 3, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Neimeth International Pharmaceuticals PLC's 344-for-317 split on February 3, 2026, every 317 shares became 344 shares.
Neimeth International Pharmaceuticals PLC has not announced a new split in our records. Its most recent split was on February 3, 2026, less than a year ago. Companies announce splits in advance, and any new NSENG:NEIMETH split will appear on this page.
Already premium?